• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100139
Device Problems Shelf Life Exceeded (1567); Low Test Results (2458)
Patient Problem Misdiagnosis (2159)
Event Date 05/22/2014
Event Type  Injury  
Event Description
Caller alleging discrepant inratio value.On (b)(6) 2014, inratio 2.2 lab 8.0.Time between testing 2 hrs.Strips were past expiration date.Pt's therapeutic range 2.0 - 2.5.Pt hospitalized on (b)(6) 2014 for possible pneumonia.Lab upon admission was 8.0.Customer unable to provide treatment or diagnosis.Believes pt was administered vitamin k based on lab result; unsure of dosage.Strips were expired.Pt was discharged on (b)(6) 2014.Lab inr taken on (b)(6) 2014 (day after discharge) was 5.4.Pt was discharged on (b)(6) 2014.Lab inr taken on (b)(6) 2014 (day after discharge) was 5.4.No add'l info available.
 
Manufacturer Narrative
Investigation pending.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
san diego CA
Manufacturer Contact
ya-ling king
9975 summers ridge rd
san diego, CA 92121
8588052084
MDR Report Key4009627
MDR Text Key4957723
Report Number2027969-2014-00627
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 06/05/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/01/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number100139
Device Lot Number312111
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/05/2014
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
COUMADIN: 6.0 MG P.O. DAILY EXCEPT TUESDAY; HYDROCODONE 5 PER 325 ONE TABLET P.O. -; Q.4H. P.R.N; LEVOTHYROXINE-75 MCG P.O. DAILY; ZANTAC-300 MG P.O. DAILY; LASIX-40 MG 1 P.O. EVERY OTHER DAY; P.O. Q.I.D.; CARBIDOPA/LEVODOPA-5 PER 250 ONE TABLET-; RANEXA-500 MG P.O. B.I.D; ASPIRIN 325 MG P.O. DAILY; DICYCLOMINE-10 MG P.O. Q.I.D; INRATIO MONITOR: SERIAL #(B)(4); PERMARIN VAGINAL CREAM 0.625 MG/GM, 0.5 GM 2/WK; MIRAPEX-2 MG P.O. AT BEDTIME; LANTUS-20 UNITS SUBCUTANEOUS AT BEDTIME; GLIPIZIDE-5 MG P.O. DAILY; LOSARTAN-25 MG 1 P.O. Q.I.D.; PROZAC-20 MG P.O. DAILY
-
-